Active substanceSulfacetamideSulfacetamide
Similar drugsTo uncover
  • Sulfacetamide
    drops d / eye 
    ESKOM NPK, OAO     Russia
  • Sulfacil sodium
    drops d / eye 
    UPDATE OF PFC, CJSC     Russia
  • Sulfacil sodium (Albucide)
    drops d / eye 
    LEKKO, ZAO     Russia
  • Sulfacil sodium-Vial
    drops d / eye 
    ALVILS, LTD.     Russia
  • Sulfacil sodium-DIA
    drops d / eye 
  • Sulfacil sodium-SOLOfarm
    drops d / eye 
    GROTEKS, LLC     Russia
  • Sulfacil sodium
    drops d / eye 
  • Sulfacil sodium
    drops d / eye 
    FARMAK, PAO     Ukraine
  • Sulfacil sodium
    drops d / eye 
    SYNTHESIS, OJSC     Russia
  • Sulfacil sodium
    drops d / eye 
    VIPS-MED, LLC     Russia
  • Sulfacil sodium
    drops d / eye 
  • Sulfacil sodium
    drops d / eye 
    YUZHFARM, LLC     Russia
  • Sulfacil sodium
    drops d / eye 
  • Sulfacil-sodium-MEZ
    drops d / eye 
  • Dosage form: & nbspEye drops.
    Composition:
    Composition per ml:
    active substance: sodium sulfacetamide - 200 mg;
    Excipients: sodium thiosulfate - 1.5 mg, hydrochloric acid 1 M solution - up to pH 7.7-8.7, water purified - up to 1 ml.
    Description:Transparent colorless or slightly yellowish liquid.
    Pharmacotherapeutic group:Antimicrobial agent - sulfonamide.
    ATX: & nbsp

    A.07.A.B   Sulfonamides

    Pharmacodynamics:
    Antimicrobial bacteriostatic agent, sulfanilamide. The mechanism of action is associated with competitive antagonism with PABA and inhibition of dihydropteroate synthetase, which leads to a disruption in the synthesis of dihydrofolic acid and, ultimately, its active metabolite of tetrahydrofolic acid, necessary for the synthesis of purines and pyrimidines.
    It is active against Gram-positive and Gram-negative cocci, Escherichia coli, Shigella spp., Vibrio cholerae, Clostridium perfringens, Bacillus antracis, Corynebacterium diphteriae, Yersinia pestis, Chlamydia spp., Actinomyces israelii, Toxoplasma gondii.
    Pharmacokinetics:With topical application of Cmax sulfanilamides in the cornea (about 3 mg / ml), the anterior chamber moisture (about 0.5 mg / ml) and iris (about 0.1 mg / ml) is achieved in the first 30 minutes after application. Some amount (less than 0.5 mg / ml) is stored in the tissues of the eyeball for 3-4 hours. If the epithelium of the cornea is damaged, the penetration of sulfonamides is enhanced.
    Indications:Conjunctivitis, blepharitis, purulent corneal ulcer, prevention and treatment of blenarus in newborns, gonorrhea and chlamydia eye diseases in adults.
    Contraindications:Individual hypersensitivity to the components of the drug.
    Pregnancy and lactation:Sufficient experience in use during pregnancy, breast-feeding is not. It is possible to use sulfacetamide to treat pregnant and lactating mothers as prescribed by the doctor if the expected curative effect exceeds the risk of possible side effects. Sulfonilamides penetrate the placenta and into breast milk.
    Dosing and Administration:Bury in a conjunctival bag for 1-2 drops 5-6 times a day. For the prevention of blennery in newborns - 2 drops in each conjunctival sac immediately after birth and 2 drops - after 2 hours.
    Side effects:Burning, lacrimation, itching, itching in the eyes, allergic reactions.
    Overdose:
    Data on drug overdose are absent.
    Interaction:The combined use with procaine and tetracaine reduces the bacteriostatic effect of sodium sulfacil. The incompatibility of sulfacyl sodium is observed when it is used together with silver salts. Simultaneous administration with chloramphenicol increases the risk of side effects of the latter.
    Special instructions:
    Patients who are hypersensitive to furosemide, thiazide diuretics,derivatives of sulfonylureas or inhibitors of carbonic anhydrase may have increased sensitivity to sulfacetamide.
    Form release / dosage:
    Eye drops 20%.

    Packaging:
    To 5, 10 ml in sterile polymer bottles-droppers, hermetically sealed by polymer stoppers, droppers and lids.

    By 5, 10 ml in sterile polymer bottles-droppers, manufactured by technology

    "blow-fill-seal" blow-fill-seal "on the production line of Bottelpack, hermetically sealed with screw caps.

    For 1 polymer bottle-dropper along with the instruction for medical use is placed in a pack of cardboard.
    Storage conditions:
    In the dark place at a temperature of no higher than 25 ° C.
    Keep out of the reach of children.
    Shelf life:
    2 years.
    The bottle-dropper should be used after opening for 30 days.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-000174
    Date of registration:17.01.2011
    The owner of the registration certificate:SLAVYANSKAYA APTEKA, LLC SLAVYANSKAYA APTEKA, LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp03.09.2015
    Illustrated instructions
      Instructions
      Up